Volume 95 Issue 31 | p. 17 | Concentrates
Issue Date: July 31, 2017

Lonza invests in modular production

Department: Business
Keywords: biologics, Lonza, Switzerland
[+]Enlarge
A rendering of new facilities Lonza plans to build at its Visp, Switzerland, site.
Credit: Lonza
A rendering of new facilities Lonza plans to build at its Visp, Switzerland, site.
 
A rendering of new facilities Lonza plans to build at its Visp, Switzerland, site.
Credit: Lonza

The big contract manufacturer Lonza will build facilities at its Visp, Switzerland, headquarters site to house modular biomanufacturing units that will be marketed under the name Ibex Solutions. The first of five planned buildings will house a previously announced joint venture with Sanofi. Because the firm will build ahead of demand, customers can reduce their time to market for new biologic drugs by 12 months or more, Lonza says. The initiative will create several hundred new jobs, the company adds.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment